Related Experiment Video
Updated: Jun 10, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Comparing exercise in Parkinson's disease--the Berlin LSVT®BIG study.
Georg Ebersbach1, Almut Ebersbach, Daniela Edler
1Movement Disorders Clinic, Beelitz-Heilstätten, Germany. ebersbach@parkinson-beelitz.de
Summary
LSVT®BIG therapy significantly improved motor function in Parkinson's disease (PD) patients compared to Nordic Walking or home exercises. This intensive, high-amplitude movement training offers a promising physiotherapy approach for PD motor symptoms.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Movement Disorders
Background:
- Physiotherapy is a cornerstone in managing Parkinson's disease (PD).
- Controlled studies comparing active physiotherapy interventions are limited.
- LSVT®BIG, an intensive high-amplitude exercise program, has emerged as a novel approach.
Purpose of the Study:
- To compare the efficacy of LSVT®BIG against Nordic Walking and a home exercise program in patients with mild to moderate PD.
- To evaluate the impact on motor function as measured by the Unified Parkinson's Disease Rating Scale (UPDRS).
Main Methods:
- A randomized comparative study involving 60 PD patients.
- Three groups: LSVT®BIG (one-to-one), Nordic Walking (group), and Home exercises (non-supervised).
- 16 hours of supervised training over 4-8 weeks, with outcomes assessed at 16 weeks via blinded UPDRS motor score video rating.
Main Results:
- Significant group differences in UPDRS motor score favoring LSVT®BIG (P < 0.001).
- LSVT®BIG showed a mean improvement of -5.05, while Nordic Walking and Home groups showed deterioration (0.58 and 1.68, respectively).
- LSVT®BIG also outperformed other groups in timed mobility tests; no significant differences in quality of life (PDQ39).
Conclusions:
- LSVT®BIG is an effective physiotherapy technique for improving motor performance in Parkinson's disease.
- The intensive, high-amplitude exercise approach demonstrates superior outcomes compared to Nordic Walking and home exercises for motor symptoms.
- Further research may explore long-term effects and quality of life impacts.
Related Concept Videos
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
